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Toxicity Modeling and Prediction with
Pattern Recognition
by Svante Wold*, William J. Dunnt and Sven Hellberg*
Empirical models can be constructed relating the change in toxicity to the change in chemical structure
for series of similar compounds or mixtures. The first step is to translate the variation in structure to
quantitative numbers. This gives a data table, a data matrix denoted by X, which then is analyzed. The
same type of the models can be used to relate the variation of in vivo data to the variation of a battery
of in vitro tests.
A single data analytical model cannot be applied to a set of compounds of diverse chemical structure.
Forsuchdatasets, separate models mustbedeveloped foreach subgroupofcompounds. Thedataanalytical
problem then partly is one of classification, pattern recognition (PARC). The assumption of structural
and biological similarity within each subset ofmodeled compounds is then essential for empirical models
to apply.
PARC is often used to classify compounds as active (toxic) or inactive. The data structure is then often
asymmetric which puts special demands on the data analysis, making the traditional PARC methods
inapplicable.
Depending on the desired information from the data analysis and on the type of available data, four
levels of PARC can be distinguished: (I) the data X are used to develop rules for classifying future
compounds into one ofthe classes represented in X; (II) same as I, but the possibility offuture compounds
belonging to "unknown" classes not represented in X is taken into account; (III) same as II, plus the
quantitative prediction ofone activity variable (here toxicity) in some classes; (IV) same as III, but several
quantitative activity (toxicity) variables are predicted.
Introduction
Pattern recognition (henceforth briefly PARC) and
related multivariate data analytical methods have re-
cently been applied to the problem of predicting the
biological activity of chemical compounds from their
chemical structure. Structure-toxicity models can be
seen as a special, albeitimportant, case. Unfortunately,
several of the published applications are merely ex-
amples ofspurious correlations because simple chemical
and statistical rules have not been obeyed (1,2).
Recently an understanding has emerged of how and
when empirical mathematical models can be used in the
modeling and prediction ofthe biological activity (1-3).
These models usually involve several variables describ-
ingthe chemical structure ofthe compounds. Moreover,
although it is sometimes stated otherwise (4-6), the
models are usually only locally applicable within series
of congeneric, structurally similar, compounds. Hence,
for sets of structurally diverse compounds, one model
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must be formulated for each biologically and chemically
similar subset. Consequently, the data analytical prob-
lem then is partly one of classification, PARC.
We shall here discuss the application ofPARC in the
modeling and prediction oftoxicity. Some emphasis will
be given to pitfalls and commonly made mistakes. This
is because the area is ofsuch importance. Mistakes and
overstated results may directly affect human safety.
Form of Pattern Recognition Problems
and Data Sets
PARC applieswhenmultipledata(variables) areused
to characterize a set of "objects," here compounds or
mixtures. The objects are divided into two sets, the
training set and the test set. The training set is often
further divided into several subsets, classes of objects
with inherent similarity. Thus the available data have
the form shown in Figure 1.
We here emphasize that data do not appear like this
automatically. As the first phase, a given problem must
be translated to one that can be handled by PARC.
Classes, variables, and objects must be specified or se-
lected according to available knowledge. The subse-WOLD, DUNN, AND HELLBERG
varlable
nl
.... k p x
variable
obyec/
2
x
FIGURE 1. The data X with elements Xik (compound i and variable
k) for PARC levels I and II.
quent data analysis is the simplest part ofthe problem,
but we must be aware of the possibilities to analyze
various types ofdata to be able totranslate ourproblem
efficiently in the first phase.
The scope of PARC data analysis is partly one of
classification. The training set data are used to develop
mathematical rules which then can be used to assign
new objects to one of the classes on the basis of the
same type of data measured on these new objects.
In case the training set consists ofjust a single class,
the classification of new objects corresponds to finding
out if they are similar to the training class or not.
Inthe analysis ofstructure-activityrelationships, the
simplest level of PARC outlined above-henceforth
called PARC level I-is rarely sufficient. One cannot
be certain that all compounds, neither in the training
set nor in the test set, indeed belong to one ofthe given
classes. The possibility of new unexpected classes must
be taken into account, i. e., the possibility that a com-
pound is an "outlier" to the given classes must be con-
sideredinthe dataanalysis. SuchanalysisisPARC level
II.
In many applications one desires also to get a quan-
titative model of the relation between the potency of
the compounds and their structure. If this potency is
measured by a single variable-here denoted y-we have
PARC level III. The structure data X are then used to
(a) classify compounds into one of the given classes or
as outliers and (b) to predict the value of the activity
variable y. Whenthe activityisquantitatively measured
by several variables, giving the activity matrix Yg for
class g in the training set, we have, finally, PARC level
IV. The scope is the same as level III except that all
the multiple y-variables enter the models simultane-
ously. Thus we then have the data shown in Figure 2.
Thenaturallevelfortheanalysisofstructure-activity
relationships is, we believe, PARC level IV. This is
because a single structural variable rarely is able to
capture the complex effects ofmodifyingchemical struc-
ture: hence, multivariate data X. Analogously, a single
activity measurement can rarely describe the state of
a biological system and how this state is affected by
chemical compounds. Indeed, in pharmacological and
toxicological investigations, multiple activity data are
usually measured, but for some strange reasons, rarely
analyzed properly as a set ofmultivariate Y data. This
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FIGURE 2. The data set of PARC levels III and IV consists of two
matrices, X and Y, both divided into a number of class training
sets plus a test set. Usually the test set daya ofthe Y matrix are
initially undefined. The number of y variables q is one for PARC
III and two or larger for PARC IV. The scope of the PARC
analysis is to develop rules for classification on the basis of the X
dataplus models forthe quantitative prediction ofYfromX. These
models are usually different for the different classes.
may be due to a lack ofknowledge ofthe availability of
appropriate data analytic methodology.
Recent Developments in Data Analysis and
the Effect on QSAR
Applied mathematics has lately provided new tools
of data analysis. In particular, it is now possible si-
multaneously to analyze the values of many variables
and theirjoint influence on a set ofother variables. This
can be done even for a limited number of cases-here
compounds or mixtures-still keeping the risk for spu-
rious results small and under control.
Hence more realistic data sets can now be analyzed
in applications of quantitative structure activity rela-
tionships (QSAR) including structure-toxicity models.
The toxicity of a set of compounds can be measured in
several different waysgivingmultivariate activity data.
The "block" oftoxicity variables can be modeled in terms
of a "block" of a great number of structure descriptor
variables. And this for a number of compounds which
may be small compared to the number of variables in
any or both blocks.
"Biological activity," e. g., toxicity, is usually the re-
sult of a complicated system of "fundamental pro-
cesses." Therefore, several biological measurements and
tests are usually needed to "capture" the nature ofthis
activity. Analogously, the modification of chemical
structure and its influence on the biological activity needs
a substantial number of variables, since the number of
possible types ofchemical-biological interactions is large.
Thus the change ofany part of a molecule induces changes
in lipophilicity, steric factors, the electron distribution,
hydrogen bonds, and so on.
The traditional PARC methods such as linear dis-
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criminant analysis and the linear learning machine are,
like multiple regression, severely restricted in chemical
applications because they need the number of cases
(compounds) to substantially exceed the number ofvar-
iables in the analyzed data set. Efforts to get around
this condition based on the selection ofvariables-often
stepwise-usually does not solve the problem. On the
contrary, while stepwise variable selection often leads
toapparentlyniceclassifications orcorrelations, therisk
for the results to be spurious is embarrassingly high
(1,2).
However, projection methods such as principal com-
ponents analysis (7,8) and partial least-squares model-
ing in latent variables (PLS) (8,9) can deal with large
numbers ofboth dependent variables (y) and predictor
variables (x) and their relationships without increasing
the risk for spurious results. This is because the data
in each block (Y and X) are separately contracted to a
few "latent" variables which then are related to each
other.
Since the contraction is made in a statistically con-
trolled way separately for each block, and since only so
few latent variables are extracted that are far fewer
than the number of cases, the resulting relations be-
tweenthe blocks ofvariables are significantand the risk
for spurious correlations plaguing the traditional meth-
ods is small and kept under statistical control.
With these projection methods, QSAR data can now
be effectively and appropriately analyzed (10,11). Mul-
tivariate activity data can be related to multivariate
structure descriptor data. Whenchemically diverse sets
ofcompounds are investigated, they can be divided into
homogeneous subsets, for which separate models can
be constructed even ifthe number ofcompounds in the
subsets becomes small.
Models Can be Constructed Only for Sets
of Similiar Compounds
The fact that only (sub)sets of chemically and phar-
macologically similar compounds can be modeled has
previously been an obstacle. Since the data analytic
methods could not deal with the small subsets and large
numbers of variables, the problem was ignored and
models constructed for larger sets of structurally di-
versecompounds. However, thissubstantiallyincreases
the risk for spurious results because the cases (com-
pounds) are no longer statistically independent. If this
is not realized, the statistical significance is evaluated
with the incorrect number of degrees of freedom and
the resulting apparent probability levels are grossly in-
flated (2).
This, in turn, has led to the erroneous belief that in
fact PARC and sometimes MR can be applied to struc-
turally diverse setsofcompounds. When one scrutinizes
the mathematical foundation ofempirical structure-ac-
tivity models, one immediately realizes that this is an
impossibility. If, for instance, some compounds are ac-
tive according to one biological mechanism and some
others are active according to another mechanism, any
chemist knows that these two types ofcompounds can-
not simultaneously be entered into the same model be-
cause a change in chemical structure affects the two
mechanisms in two different ways.
Analogously, structurally diverse compounds cannot
be entered into the same model because a small change
in structure in one type of compounds has different
chemical and biological effects than the same small
change in another type of compounds.
This problem has now been sorted out and it has been
shown that allclaims that structure-activity models can
be formulated for structurally diverse compounds are
erroneous and based on incorrect data analysis and in-
correct evaluation of statistical significance levels (2).
The only problem remaining is one of psychology. We
must accept that the construction of structure-activity
models is difficult, demanding profound biological
knowledge about the modeled system. Such knowledge
often does not exist and therefore the modeling often
fails. There is no fast and simple way to obtain
information.
Valid Ways To Construct
Multivariate Models
We shall discuss below what one can do and cannot
do in the context ofstructure-activity modeling, in par-
ticularwhen the biological activity relates to "toxicity."
To facilitate a rational discussion, we divide the QSAR
problem into a number ofseparate subproblems. Though
these subproblems are only loosely connected, the data
analysis has a strong influence on the earlier parts of a
QSAR investigation. In particular, the design of an in-
vestigation is strongly affected by the knowledge that
data with several toxicity measures (Y) are much more
informative than a single measurement and that such
multivariate activity data indeed can be related to a
multitude of structural data (X).
Modeling in General
The idea ofmodeling is closely related to the analogy
concept. The idea is to construct models which behave
analogously to the system we really wish to study and
predict. Models are practical because they are simpler
to study and thereby even easier to "understand." They
are also cheaper and ethically preferable to manipulate
and observe.
In toxicity studies, a number of model types can be
seen. All of them can with advantage be used "multi-
variately." The relation between the "measurements"
made on the model's system and the "real system" can
be qualitative (classification, PARC levels 1 and 2, see
above) or quantitative or both. Chain models can also
be envisioned as exemplified by type 6. The pertinent
system for which we wish to draw conclusions-the "real
system" below-usually isman, but often othersystems
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are of interest, e.g., ecological systems, with the im-
plicit assumption that detrimental effects of chemical
agents on these systems indicate that they are harmful
also for man.
(1) Model: A mathematical description ofthe chemical
structure. Real system: The measured biological activ-
ity in one or several tests (in man or in an animal sys-
tems or in a cell test system).
(2) Model: Chemical and physical measurements on
chemical compounds. Real system: as in 1.
(3) Model: In vitro tests. Real system: An animal, say
rabbit, or man.
(4) Model: Acombinationofinvitrotestsandchemical
structure description. Real system: as in 3.
(5) Model: Oneorseveralanimalsystem. Realsystem:
Man or an ecological system.
(6) Models: Chemical structure (block 1), invitrotests
(block 2), animals (block 3). Real system: as in 5. A
multiblock chainmodelcanbeorganized as, forinstance,
block 1 -- block 2 -* block 3 -> block 4.
We shall here discuss mainly models oftype 1 and 2,
relations between chemical structure and biological ac-
tivity. However, the general approach and the data an-
alytical methods is equally applicable to models oftypes
3-6. The PLS models discussed below canhandle chains
ofblocks with any number from two to about a hundred
blocks.
HardAndSoftModels. We distinguish between hard
(fundamental) and soft (empirical) models and argue that
the latter at present are more suitable for toxicity models
because of the general lack of knowledge of the fun-
damental mechanisms involved.
Hard models incorporate assumptions about the
mathematical form ofthe model, derived from the "fun-
damentalknowledge" aboutthe studied system. Kinetic
models in the form of systems ofdifferential equations
are typical examples of hard models.
Soft models, in contrast, incorporate as few assump-
tions as possible, usually only assumptions about hom-
ogeneity and continuity of the data. The homogeneity
assumption in the present context corresponds to the
assumption that the biological data measure "the same
mechanism" of toxicity over the set of studied com-
pounds. Hence, empirical models are necessarily local
in their nature. Each model is valid oAly for a set of
biologically and thereby also chemically similar com-
pounds. Claims that empirical models can be con-
structed for sets ofcompounds with diverse structures
are wrong as discussed above and based on an incorrect
statistical evaluation of sampling artifacts.
The continuity assumption means that a small change
in chemical structure shall also cause a small change in
the measured toxicity. Though seemingly trivial, this
assumptionisessentialinanykindofempiricalmodeling.
The lack of assumptions in empirical models is com-
pensated by the use ofmultivariate data. Several mea-
surements are used to characterize both the biological
activity and the structure. These data inserted into the
soft model give "patterns" specific for each type ofsys-
tems. These "patterns" can then in retrospect be used
to check if the "fundamental knowledge" is consistent
with the actual data. Additionally, the patterns can be
used to predict the biological activity (Y) of new com-
pounds from their structural descriptors (X).
Soft multivariate models, below exemplified with the
PC and PLS models, can be used to analyze experi-
mental data and make predictions long before sufficient
knowledge is available to apply fundamental, hard,
models. The knowledge about a system is never com-
plete, in particular not in a research situation. Hence,
soft models are the best choice in early stages of an
investigation and for new subproblems in older inves-
tigations. Whenthe empiricalknowledge increases, this
can be incorporated into the models, making them less
soft and more hard.
The Analogy Assumption. In the present context,
one further crucial assumption is made, namely, that of
analogy: that the variation in structure canbe described
by numbers which are derived from chemical standard
reactions. Thus, one assumes that the change ofa sub-
stituent in the studied set ofcompounds, say from methyl
to chloro, is causing a change in toxicity that can be
modeled intermsofthe same "effects" asinanensemble
ofchemical standardreactions. The change frommethyl
to chloro induces a certain change in (a) pKa of para-
substituted benzoic acids, (b) the distribution between
octanol and water ofpara-substituted phenols, (c) the
rate ofester hydrolysis ofalpha-substituted acetic acid
ethyl esters, and so on. These changes can be described
as numerical valuesin different variables corresponding
to (a), (b), and (c), etc. By selecting a sufficient range
ofchemical standard reactions, we hope to "capture" all
effects by which a change in a substituent can change
chemical reactivity.
We then assume that the toxicity is affected by the
same effects, but in an unknown combination. Thus,
toxicity is seen as a chemical reaction, albeit rather
complicated. As will be discussed below, the set ofstan-
dard reaction data can thenbe combined in aPLS model
which well predicts the change in toxicity which takes
place when a change is made in the chemical structure.
Again, since chemical effects combined differently in
differentreactions, themodelsapplyonlyforchemically
similar compounds causing toxicity by the same biolog-
ical mechanism.
A greater variation in chemical structure, and thereby
in the way structure influences toxicity, must therefore
be handled by an ensemble of disjoint models, one for
each subset ofsimilarcompounds. Forneighboring sub-
sets, themodelsmaybejoinedbysoftrelationsbetween
the latent variables.
Design, Selection ofCompounds. With any type of
models-hard or soft-the selection ofwhat and where
to measure is of utmost importance for the later appli-
cation of the models for predictions. With any model,
extrapolations are imprecise fMr outside the domain of
260TOXICITY MODELING AND PREDICTION
the data onwhich themodel was "calibrated."Therefore
each structural "factor" must be varied to "span" the
domain in which predictions are sought.
As shown by statistical investigations ofdesign strat-
egies, it is extremely inefficient to change one factor at
atime in empirical modeling (12). Inthe present context
of structure-activity models, this means that one must
not construct the set ofstudied compounds by changing
one structural element, one substituent, at a time. If,
for instance, we have three substituent sites and we
can at each site put the four substituents a, b, c or d,
aninefficiently selected set would be: aaa, baa, caa, daa,
aba, aca, ada, aab, aac and aad. This set gives no in-
formation about the joint influence ofthe three sites on
the biological activity. A much better set derived by
fractional factorials (12,13) would be aaa, acd, bbd, bda,
cbb, cdc, dac and dcb.
The Number of Compounds. With the projection
methods discussed here, the relation between the num-
ber of objects (here compounds) and variables is un-
important. To span the abstract space of chemical
structural variation for a given class of compounds, a
certain minimal numberofcarefully selected compounds
is necessary. In case we can divide the chemical struc-
ture into a fixed "backbone" plus a number (m) of sub-
stituent sites, the minimal set ofcompunds is 8 x 2-',
i.e., 8 for one substituent site, 16 for two, 32 for three,
64 for four sites, etc. The selection ofthese compounds
is made by fractional factorial designs (12,13) in the
variables used as structural descriptors, four to five per
site (see below). These numbers may seem large, but
we must remember the number of possible compounds
which is at least 100"', i.e., 100 millions for the case with
four sites.
Biological Data
The characterization ofthe toxicity or otherbiological
effect of a chemical compound is best made by a mul-
titude of variables. Such multivariate data allow the
independent judgment of the quality of the biological
variables and also the resolution of these data into dif-
ferent "factors" as discussed below.
In traditional science, there is a strong tendency to
try to characterize the state of a system by a single
variable. The chemical potential is a typical example
from physical chemistry, and LD50 an example from
toxicology. The more complicated an investigated sys-
tem is, however, the more unlikely it is that this single
variable is sufficient in a given problem. Thus, in the
typical study of relationships between chemical struc-
ture and toxicity, one must measure toxicity in several
different ways, preferably in several different test sys-
tems, to capture most ofthe different ways the chemical
compounds can affect biological systems.
The limitation ofthe number ofdifferent toxicological
measures one should include in an investigation is mainly
economical. The larger the number of different mea-
surements, the more information one obtains, but at a
greater cost. At some point the marginal price of the
next increment ofinformation is too high and the prac-
tical limit is reached.
Chemical Structure and Its Quantification
To apply PARC data analysis, the variation in chem-
ical structure between the investigated compounds must
firstbetranslated tovaluesofvariables. Themostdirect
and usually most informative way is to use chemical and
physical properties measured on the chemical com-
pounds. Lipophilicity (log P octanol/water), acid-base
properties (pKA), solubility in water, IR and NMR spec-
tra, and reactivities in model reactions are often rel-
evant in structure-activity and toxicity studies. We note
that to get these measurements, the compounds must
actually exist in the real world (models type 2).
In models of type 1, one wishes to construct theo-
retical models so that predictions can be obtained for
new compounds before they are actually synthesized
and available for real measurements. Ifthe compounds
can be divided into a fixed structural backbone plus
substituent sites, this task is reduced to the simpler
problem of describing the substituents sitting at the
different sites. The description ofthe electronic type of
substituent demands two variables (14,15), anothervar-
iable is needed for lipophilicity (16), another one or two
for steric size (17,18); in total at least four or five struc-
tural variables per substituent site are required.
In the more difficult case, when a common backbone
cannot be distinguished, there is presently no general
way to describe chemical structure. The occurrence of
structural fragments hasfrequentlybeenused in PARC
QSAR applications, but this is not recommended, since
such variables lack the continuity properties required
for PARC. Moreover, their use seems to increase the
risk for spurious correlations (2). Finally, predictions
are difficult to make for compounds with new structural
fragments not represented in the training set.
Wise and Cramer (19) and Marshall (20) have prom-
ising approaches to deal with the quantification of the
structural variation offlexible molecules, but as yet the
experience is not sufficient to recommend these ap-
proaches for routine applications.
Quantum mechanical indices and energy levels may
be useful both for the simpler case with backbone and
substituents and for the case with flexible molecules.
Molecular mechanics is possibly useful to calculate con-
formations of such molecules, but also these latter ap-
proaches are still far from routine.
As discussed above, thelargerthe numberofrelevant
variables that are used to describe the chemical struc-
ture, the better. The data analysis is not complicated
by a multitude of chemical descriptors.
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FIGURE 3. By PC analysis, the objects-rows in X represented as points in a p-dimensional space-are projected down on a few-dimensional
hyperplane (left). Algebraically, this corresponds to the decomposition of X into a mean vector plus the product of two matrices T and P
plus residuals E (right).
Data Analysis
The PARC methods used in structure-activity and
toxicity studies usually arelevel-onemethods; the linear
learning machine (LLM), linear discriminant analysis
(LDA), or K nearest-neighbor methods (KNN). As dis-
cussed above and in the literature (2,3,10,11), these
methods are not suitable for these applications. First,
they cannot in a statistically appropriate way cope with
outliers. Second, LLM and LDA are not applicable when
the number of structure descriptor variables (X) ex-
ceeds the number of compounds in the training set.
Methods of variable selection are then applied which
greatly increase the risk for spurious results (1,2). In
addition, the data are often scaled to enhance the class
separation, which also increases the risk for spurious
results even with the otherwise robust KNN method.
To formulate quantitative models ofstructure-activ-
ity relations, multiple regression (MR) is commonly used.
Since MR has the same unfortunate limitation as LDA
and LLM with respect to the number of X variables,
stepwise variable selection is also often used here. The
resulting correlations are then often not statistically
valid because the effect ofthe variable selection on the
statistical significance levels is not taken into proper
account (1). MR cannot simultaneously model several
activity variables, which is another reason why it is less
useful in the present context. Finally, MR gives un-
predictable and little useful results when the X matrix
is collinear, which is often the case in QSAR due to the
difficulties in applying traditional experimental design
(11).
Projection Methods, Principal Components, and
PLS. An efficient way to analyze one or several data
tables is to project the tables down on smaller tables
with orthogonal columns. With PARC level I and II,
the X matrix of each class (denoted by Xq for class g)
is projected down on a few column matrix Tg by means
ofthe projection matrixPg. Geometrically, this is equiv-
alent to representing each object vector as a point in a
p-dimensional space (p is the number of x variables) and
then modeling the point swarm of each class as a few
dimensional hyperplane. This is indicated in Figure 3
for a single class. In statistics this is called principal
components (PC) analysis of the class data matrix.
This gives a model ofthe class in terms of the "class
middle"-the vector x)-and the direction coefficients
of the hyperplane-the matrix P. New objects can be
classified as similar to the class or not in terms oftheir
calculated distance in p-space to the class hyperplane.
Mathematically, this distance is calculated by a simple
multiple regression with the new object data as the
"dependent" variable and the rows in the P matrix as
predictor variables. Objects far from all class models
are labeled as outliers.
We realize that the projections can be calculated re-
gardless ofthe number of x variables (p) and its relation
to the number of objects in a class (ng) or in the total
x
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FIGURE 4. In PARC level IV, the data of one class are represented as points in two spaces, one for X and one for Y. The PLS method
projects these points down on hyperplanes in the two spaces. Here the simplest hyperplanes are shown, i.e., lines. These projections are
made by least-squares so that the t and u coordinates ofthe objects correlate and so that hyperplanes describe much of the data variation
in the X and Y spaces, respectively. Hypercylindrical tolerance intervals are constructed around each class model on the basis ofthe scatter
of the training set points from the model. New objects falling inside the X tolerance interval are assigned to the class and predictions of
its activity values Y are obtained from the chain t-u-Y
training set (n). In fact, the projections are more stable
the larger the number of relevant x variables.
This makes this PARC method-the SIMCA method
(2,3,8,10,11)-well suited for structure activity and
toxicity relationships. Separate PC models are calcu-
lated for each separate class-the subset of chemically
similar compounds. The fact that these subsets consist
of a limited number ofcompounds in comparison to the
numberofstructure descriptorvariables isnolimitation
for the SIMCA method.
WithPARClevels III and IVwehavealsoa Ymatrix.
This can be represented in a separate space-the Y-
space-and the Y matrix of each class can separately
be projected down on a hyperplane by means of the
projection matrix Q. The object coordinates in this hy-
perplane comprise the matrix U. With the PLS method
(partial least-squares models in latent variables) the
projections of the X and Y matrices can be made si-
multaneously so that also the correlations between the
t and u vectors (columns in T and U) are optimized,
thereby creating a connection between the two spaces
(9,11). This gives a model for each class which can be
used (a) to classify new objects (compounds) as similar
to the class or not and (b) for compounds similar to the
class, to obtain predictions ofthe y data in terms ofthe
connections between t and u (Fig. 4).
When only a single Y variable is available (PARC
III), the Y-space is one-dimensional. Then noprojection
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is calculated in Y-space, but this y variable is used di-
rectly as the u-vector in each model dimension. In this
case, PLS converges towards multiple regression (MR)
with increasing model dimensionality. Thus, if indeed
MR is appropriate for the given data, PLS will give the
same results. In practice, however, PLS usually gives
far fewer dimensions because ofcollinearities in X and/
or the presence of irrelevant variables in X.
The number of model dimensions in the PC and PLS
models is determined by cross-validation. Part of the
class data set is kept out from the computation of the
class model and then predicted by the resulting model.
The predictions are compared with the actual values
and then another part of the data is kept out, a new
model calculated, etc., until each data element has been
kept out once and only once. This is made for each
dimension, and that model dimensionality is selected
which gives the best predictions of the kept out data.
Estimation ofthe Reliability ofResults. The use
of cross-validation with PC and PLS models gives a
reliable but somewhat conservative estimate of the
amount ofinformation in the data relevant for the cur-
rent problem. Moreover, since the class models are de-
veloped separately for the different classes without any
enhancement of class differences, the resulting class
separation is not overestimated. This is in contrast to
LLM and LDA, which find the maximal separation of
the classes. This is much overestimated, particularly
when the number of x variables is large.
Similarly, multiple regression (MR) overestimates the
amount of variance of y explained by X. This because
MR combines the x variables to obtain the maximum
correlation with y. Again, this overestimation is severe
when the number of x variables is large, and when the
number used in the final model is reduced by stepwise
selection.
The use of cross-validation to evaluate the results of
any PARC or MR analysis would greatly reduce the
frequency of spurious results publications. Such cross-
validation mustthen beused so that all scaling, variable
selection, and data analysis is made independently for
each round of keeping part of the data set out of the
model development. The erroneous practice to use only
the final set of variables and objects and keep one out
at a time is not a proper evaluation, since it does not
evaluate the effects ofscaling and variable selection on
the results. These effects are often large (1,2).
Psychological Problems
With a proper data analysis and a proper validation
of the models, one often gets rather disappointing re-
sultsinstructure-activityinvestigations. Thisisnatural
because the studied systems are very complex, and the
knowledge about how to describe chemical structure
andits effect onbiological activity is notwelldeveloped.
Nevertheless, it is always disappointing to get diffuse
resultswithverylittleofthebiologicalactivityexplained.
One obvious way out is to use nonvalidated results of
data anayltic methods such as LLM and MR known to
give overoptimistic correlations. Since manhas astrong
desire to find positive results, there is a psychological
resistance against a proper statistical validation of sci-
entific models, including those used in toxicology pre-
dictions. This allows the publication of many dubious
correlations in the present field and even commercial
operations based on spurious models advertising that
the toxicity, mutagenicity, and carcinogenicity of ar-
bitrary untested compounds can be predicted fromjust
the structural formula of the compounds.
Asymmetric Nature of the Active-Inactive
Classification
In structure-toxicity investigations, the classification
problem is often formulated as the discrimination be-
tween active (toxic) and inactive (nontoxic) compounds.
Ifone thenapplies levelone PARC, the analysis is likely
tofailorgive spuriousresults. Thisbecausetheproblem
is not symmetric (21).
The active class may be well defined structurally and
toxicologically and thereby occupies a small regular vol-
ume in p-space. The lack of toxicity in the given bio-
logical test system, however, is not a class-defining
property. Any compound which lacks the proper struc-
tural elements needed to trigger the mechanism oftox-
icity will be nontoxic. Hence, the majority ofall billions
VarJ
0 0
0
0 0
40 0
x00
Var: 1
FIGURE 5. An asymmetric data structure with the class of active
compounds occupying a small regular volume inp-space, while the
nonactive compounds are randomly scattered in the same space.
A discriminant hyperplane (LLM or LDA) cannot in a meaningful
way separate the two classes.
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of compounds will belong to the "nonactive" class. It is
clearthatin anyconceivable space, thesenonactive com-
pounds will be randomly distributed. The active class
can be modeled, while the "nonactive" class cannot.
Level-one PARC methods such as LLM and LDA that
try to separate the two classes by a hyperplane will, of
course, fail(Fig. 5). Thisis onefurther reasonwhythese
methods cannot be recommended for structure-toxicity
relationships.
Level two PARC methods such as SIMCA apply also
intheasymmetricproblem. Providedthatthestructural
descriptors arerelevanttotheproblem, the properclass
of active compounds with similar structure can be well
approximated by a PC model. The inactive compounds
are likely to be situated outside the tolerance interval
of this model. Hence new objects can be classified as
similar to the active class (toxic) or not (Fig. 6).
We note one complication with the asymmetric prob-
lemformulation. Acompound correctly classified as non-
similar to the active class may be either inactive or
active (toxic) according to another mechanism than the
training set actives. Thus not-in-active-class does not
necessarily mean inactive. This complication follows from
the problem formulation and not from the way the data
are analyzed. Hence, the problem is the same also in
biological model systems. Lack of activity in a cell test
battery need not necessarily correspond to lack of ac-
tivity invivo, just that the model system does not apply
in the same way as before to the presently tested
compound.
Var3
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FIGURE 6. Level II PARC methods such as SIMCA work in the
asymmetric case byenclosingthe "active" class in a closed volume.
New compounds are classified as active ornonactive, respectively,
according to their position inside or outside this volume.
Summary of Statistical Requirements
Empirical modeling is based on certain assumptions
about the problem formulation and the properties ofthe
data, notably those of homogeneity and continuity. In
structure-activity and toxicity modeling, these as-
sumptions can be translated to certain chemical and
pharmacological requirements on the problem and the
data as listed below. In addition, to give maximum in-
formation, the data should be well designed and rel-
evant, both the structural and the biological activity
variation should be described multivariately.
Each model should be applied only to a set of struc-
turally and toxicologically similar compounds. Ifthe data
set contains structurally and toxicologically diverse
compounds, separate models must be formulated for
each homogeneous subgroup-proper class. We note that
this is no loss of information, since it is very easy to
distinguish between structural classes of compounds,
this distinction is not the objective of the modeling.
Iftraditional statistical methods are used forthe data
analysis, the initial set ofvariables, before any selection
and reduction, must have fewer members than a fourth
of the number of compounds in the training set. When
the number of variables is larger than this limit, or if
there are collinearities in the X matrix, linear discrim-
inant analysis, linear learning machine or multiple
regression methods cannot be used unless the data set
is reduced by independent means, e.g., by principal
components (factor) analysis.
Projection methods such as SIMCA and PLS work
also with many variables and collinear data matrices.
If the problem is formulated as active-inactive, a
method able to handle the asymmetric problem should
be used, e.g., SIMCA.
When the data set is incomplete, i.e., there are miss-
ing observations in the X and Y matrices, most data
analytical methods except projection methods (SIMCA,
PLS), fail.
The variables used for describing the structural var-
iation should be continuous, preferably directly derived
from measured data on model systems (pi, sigma and
the like).
The biological data should be relevant and precisely
measured. A lack of precision in a single variable can
be compensated by including several different variables
measured on the same system or related systems.
Each class of compounds should have a certain min-
imum size. If a single substituent site is varied, eight
compounds is minimum, 16 for two sites, 32 for three
sites, and so on. These compounds should be selected
according to an appropriate design, e.g., fractional fac-
torial. It is not correct to change one structural factor
at a time in the compound set.
We emphasize that these demands refer to models of
type 1 relating theoretical structural descriptors to tox-
icity data. In models of types 2-6, where both data
blocks X and Y consist ofmeasured data, 15 compounds
or thereabout in each class is sufficient to develop models
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in most instances. If several structural fragments can
be varied in a class, this variation must still not be made
so that one fragment at a time is varied.
Weak Points of Structure-Activity
and Toxicity Models
With the availability of modern computerized data
analytical methods the weak point in this field is not the
dataanalytical methodology. Provided thatthe problem
is correctly formulated, classes appropriately chosen,
variables correctly selected and measured, and com-
pounds correctly chosento span the structural variation
in the classes, the data analysis will extract all available
information. Hence, whenaQSAR doesnotgivedesired
results, there is usually something wrong either in the
problem formulation, in the design, in the chemical
structure desc -ntion, or in the biological data.
The most common error is the one of design, i.e., of
compound selection. One structural factor is varied at
a time or structurally diverse compounds are included
into the same single model.
We still have much to learn about which effects a
structural variation can have on chemical reactivity. If
we see biological activity as a special case of chemical
reactivity, we realize that the description of structure
in QSAR is still far from appropriate. Only for rigid
compounds with well-defined sites of substitution can
wedealfairlyroutinelywiththisproblem, butevenhere
much development of substituent descriptors relevant
for biological applications is needed. With flexible mol-
ecules, structure-reactivity and activity modeling is still
in its infancy, and validated successful applications are
very rare.
The greatest problem, however, is the specification,
selection, and measurement of the biological data. To
begin with, a good pharmacological model must be de-
veloped, a cell or an animal system that models the
effects on the system of interest, often man.
Since a model is never an exact copy of a system,
there are always imperfections in the predictions based
on the model. One way to decrease the magnitude of
these imperfections is to combine a multitude of phar-
macological and toxicological measurements into the
model, i.e., touse abattery oftests. Asindicated above,
a suitable data analysis with a projection method will
twist the battery results in a way optimal for the given
problem. We realize that this multivariate approach is
difficult to accept because we are all brought up to the
beliefthatthe scientific approach is equivalent to search
for a single "crucial variable" and to measure that with
thehighestprecision. Withtheadvent ofcomputers and
projection methods, however, the latter approach is no
longer informationally optimal, but it will take a long
time to change the scientific dogma in this respect.
Agreatdifficulty inpharmacological and toxicological
modeling is caused by the demand of homogeneity-
chemical and pharmacological similarity in the mecha-
nism of action-of the studied set of compounds. The
level ofknowledge is rarely such that this homogeneity
can be assured in advance. Hence, the collected data
are grouped and clustered, and one must be prepared
to analyze the data accordingly. Often, however, the
data do not directly contain information about inhom-
ogeneities among the compounds, in particular if only
a single activity variable (y) is available. Then only bi-
ological and chemical insight helps, but it may be in-
sufficient in new and complicated problems.
If the data are grouped, one should not try to model
them by a single relationship. If one does anyway, a
good criterion ofsuccess is that the model not only con-
nects the mean values of each group but that it also
predicts the variation in biological activity better than
chance within each subgroup. Ifnot, each subgroup acts
just like a point, and the model is just an elaboration of
a line through two points.
Examples
We shall not discuss here the applications of tradi-
tional PARC methods (LLM, LDA, KNN) to the clas-
sification of compounds as active (toxic) or inactive,
because most of these applications have been made in
such a way that the risk is high for the results to be
just spurious.
However, a number of PARC applications based on
projection methods have recently been published
(10,11,22-26). In these studies, at least the risk for spu-
rious results was kept understatistical controlby avoid-
ing stepwise variable selection and class-separation
enhancing data scaling.
Most of the data sets in these applications were to
some extent asymmetric; the "nonactive" class usually
did not have any systematic data structure that could
be modeled. This indicates that an asymmetric data
structure is a common consequence of this type of ac-
tive-inactive problem formulation.
To illustrate the projection methodology, we use a
graph from a paper recently published (11). Callen et
al. (27) published mutagenicity and toxicity data for
seven halogenated hydrocarbons. We contracted the ac-
tivity data to five y variables, four measuring muta-
genicity and one toxicity. The structural variation among
the seven compounds was described by eleven x vari-
ables, including traditional variables such as molecular
refractivity, MR, and lipophilicity (logP) andfourquan-
tum-chemically calculated variables (charges and elec-
tronegativities of carbon and chlorine atoms,
respectively).
The data set (n =7, p = lix variables, q=5y varia-
bles) is a typical one that cannot be analyzed with tra-
ditional data analytical methods. A PLS-analysis gives
two highly significant model dimensions, of which the
first is shown in Figure 7. The first structural PLS
dimension consists mainly of the traditional variables,
MR, log P, etc. Hence, most ofthe variation in toxicity
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U1
* C12C =CHCI
CHC/I .CC/4,
*CF3CHC/Br
FIGURE 7. The first latent activity variable, u, plotte
first latent structure variable t, showing a good cc
tween the Y and X space.
and mutagenicity seems to be connected to i
interactions between compound and the cell
A separate principal components analysis
matrix gives two significant dimensions desc:
of the variance in Y. This shows that the quc
biological data is high. The PLS model expla
this systematic part of Y, showing that th
some precision to gain by a better structur
tion, i.e. better X. Thus a combination of a P
of Y and a PLS analysis of X and Y indical
i.e., in which part of the model, improveme
made. It is interesting that in the present e)
model deficiencies lie in X and not, as is us
matically assumed, in the biological data, Y.
The resulting PLS model can be used alb
dictions. As anillustration, vinyl chloride wa;
by the same eleven x variables and entere
PLS model. The X vector fits the model rat}
which says that vinyl chloride is not very sin
seven-compound "training set" and thereb;
predicted biological activity is not very reliX
chloride is predicted to be about as active as
chloride, the least active ofthe training set cl
Discussion
In this article we have discussed the probl
eling toxicity from the data-analytical and i
theoretic point ofview. This has made us rat
to how "pattern recognition" and other data
notably multiple regression-usually is app
problem area. We have the strong opinion
data analytical methods are used which cor
the actual problem and data structures, little
trivial and, more seriously, misleading rest
obtained.
A lack of understanding of the necessity
C12C CC2 only homogeneous data into a single model leads to se-
verely grouped data, and the number ofreal degrees of
~cHC CHC,2 freedom is grossly overestimated. The consequence is
2-~ 2that statistically insignificant results may be thought to
be significant and spurious correlations are taken to be
real.
We know ofonly one exception in which structurally
diverse compounds may be modeled by a single equa-
tion, namely, nonspecific toxicity. This is often related
to the total lipophilicity of the compound (log P). This
total log P may be calculated approximately from frag-
ment constants (ir) (16). Thus, a model may be con-
structed whichpredictsthenonspecifictoxicityfromthe
total log P which, in turn, is predicted from the sum of
fragment contributions Fr.
The projection methods of principal components an-
alysis and PLS have the advantage ofbeing applicable
also in cases when the number of analyzed variables
'i exceeds the number of cases, systems, objects, com-
d against the pounds. Hence, there is no more need for data sets with
)nnection be- large numbers of compounds. The data can be divided
into homogeneous subsets without any loss of infor-
nonspecific mation and properly analyzed by separate models for
system. each subset.
s of the Y The fact that also several activity (toxicity) variables
ribing 95% can be modeled simultaneously makes the projection
ality ofthe models useful for data sets that are multivariate both
tins 85% of in X and Y. Since the complexity of toxicity more or
ere is still less demands such multivariate characterization, we now
al descrip- have dataanalytical methods thatdon't haveto mutilate
'C analysis the problem.
tes where, The use of multivariate X and Y data also allows the
,nts can be data analysis to separate the variation in the Y data
Kample the into a systematic part and "noise" and then further di-
ually auto- vide the systematic part into one part modeled by X
and one nonmodeled part. This allows the investigator
so for pre- totrackdeficienciesinthe model andtherebytoimprove
sdescribed it.
d into the The projection methods can handle problems on dif-
her poorly, ferent "ambition" levels from mere classification (level
nilar to the I) to the combination of classification and quantitative
y that the modeling of several activity variables (level IV). Hence
able. Vinyl the same dataanalyticalframework canbeused formost
methylene or all dataanalytical problems intoxicologicalmodeling.
ompounds. The data analytical nomenclature may in this context
be somewhatconfusing. Many chemists use pattern rec-
ognition only for problems on level I and II, and see the
quantitative modeling (levels III and IV) as totally dif-
em ofmod- ferent. With the projection methods we get allthe levels
nformation into one and the same statistical and philosophical
;her critical framework, thereby letting the problem guide the data
analysis- analysis and not the reverse.
lied in this In conclusion, we can now concentrate on the impor-
that if not tant parts ofstructure-toxicity modeling, namely to get
respond to relevant biological data, to use an informative way to
more than describe the variation in chemical structure, and, not
fits will be the least, the design problem to select representative
sets of compounds which well map the complicated ab-
to include stract spaces in which predictions are sought.
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